GlobeNewswire Inc.·Mar 16·Medicinova, Inc.MediciNova to Present Pipeline Progress at 2026 ROTH ConferenceMediciNova executives to present clinical pipeline at March 2026 ROTH Conference, conducting direct investor meetings in Dana Point. MNOVclinical trialsbiopharmaceutical
GlobeNewswire Inc.·Mar 11·NaQuantum BioPharma Adjusts Debenture Terms Amid Share Price DeclineQuantum BioPharma revises debenture offering terms following share price decline, lowering conversion price to $3.00 and increasing warrant allocation. QNTMwarrantsbiopharmaceutical
GlobeNewswire Inc.·Mar 10·NaQuantum BioPharma Launches $4M Convertible Offering to Fund OperationsQuantum BioPharma raises capital through convertible debentures and debt-to-equity conversion to strengthen balance sheet and fund business development. QNTMprivate placementcapital raising